跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OLIMEL 7.6% - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
OLIMEL 7.6%
Authorized
STANDARD
OLIMEL 7.6%
baxter corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8cd929d7316127b3
Company
baxter corporation
Type
Standard
Approval Details
Approval Id
8cd929d7316127b3
Drug Approval Canada Name
OLIMEL 7.6%
Product Name
OLIMEL 7.6%
Status
Marketed
Status Date
2021-07-26
Original Market Date
2021-07-26
Din
02477947
Drug Class
Human
Dosage Form
Emulsion
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
40:20.00
Atc Original
B05BA10 COMBINATIONS
Atc Name
b 05 ba 10
Aig Number
2052745003
Company Name
baxter corporation
Company Address
7125 Mississauga Road, Mississauga, Ontario, Canada, L5N 0C2
Active Ingredients
ALANINE
10.99 G / L
DEXTROSE
80.67 G / L
GLUTAMIC ACID
3.79 G / L
HISTIDINE
4.53 G / L
L-ARGININE
7.44 G / L
L-PHENYLALANINE
5.26 G / L
GLYCINE
5.26 G / L
L-ISOLEUCINE
3.79 G / L
L-LEUCINE
5.26 G / L
L-ASPARTIC ACID
2.2 G / L
L-PROLINE
4.53 G / L
L-TYROSINE
0.2 G / L
L-THREONINE
3.79 G / L
L-VALINE
4.86 G / L
OLIVE OIL
28 G / L
METHIONINE
3.79 G / L
SERINE
3 G / L
TRYPTOPHAN
1.26 G / L
SOYBEAN OIL
7 G / L
LYSINE (L-LYSINE ACETATE)
5.97 G / L
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8cd929d7316127b3
Type
Standard
Back to Health Canada Approvals